Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

PCVX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $35,141,433.71

Vaxcyte Insider Trading History Chart

Vaxcyte Share Price & Price History

^$86.53

▲ +0.32 (0.37%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Click here now for the urgent details.

Vaxcyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/18/2024	Andrew Guggenhime	CFO	Sell	8,000	$88.78	$710,240.00	109,491
12/9/2024	Grant Pickering	CEO	Sell	2,366	$92.25	$218,263.50	136,215
12/5/2024	Mikhail Eydelman	SVP	Sell	5,000	$91.49	$457,450.00	28,697
12/2/2024	Grant Pickering	CEO	Sell	15,000	$92.45	$1,386,750.00	450,301
12/2/2024	Jim Wassil	COO	Sell	8,000	$92.49	$739,920.00	205,695
11/7/2024	Grant Pickering	CEO	Sell	2,366	$103.89	$245,803.74	137,398
11/1/2024	Grant Pickering	CEO	Sell	15,000	$106.82	$1,602,300.00	435,219
11/1/2024	Jim Wassil	COO	Sell	8,000	$106.80	$854,400.00	205,695
10/18/2024	Andrew Guggenhime	CFO	Sell	42,000	$115.39	$4,846,380.00	90,383
10/7/2024	Grant Pickering	CEO	Sell	7,098	$109.21	$775,172.58	138,581
10/7/2024	Mikhail Eydelman	SVP	Sell	5,000	$109.27	$546,350.00	28,623
9/18/2024	Andrew Guggenhime	CFO	Sell	8,000	$115.94	$927,520.00	90,383
9/3/2024	Elvia Cowan	SVP	Sell	5,000	$107.67	$538,350.00	12,723
9/3/2024	Jim Wassil	COO	Sell	10,000	$111.93	$1,119,300.00	207,503
8/23/2024	Grant Pickering	CEO	Sell	15,000	$78.98	$1,184,700.00	478,888
7/23/2024	Grant Pickering	CEO	Sell	15,000	$84.26	$1,263,900.00	478,888
7/18/2024	Andrew Guggenhime	CFO	Sell	8,000	$81.17	$649,360.00	96,720
7/16/2024	Elvia Cowan	SVP	Sell	5,000	$85.00	$425,000.00	12,723
7/8/2024	Elvia Cowan	SVP	Sell	5,000	$80.00	$400,000.00	12,723
7/1/2024	Grant Pickering	CEO	Sell	2,616	$76.33	$199,679.28	143,438
7/1/2024	Jim Wassil	COO	Sell	3,000	$76.34	$229,020.00	210,503
7/1/2024	Mikhail Eydelman	SVP	Sell	1,667	$76.37	$127,308.79	30,826
6/24/2024	Grant Pickering	CEO	Sell	15,000	$75.64	$1,134,600.00	478,888
6/3/2024	Grant Pickering	CEO	Sell	2,616	$72.06	$188,508.96	144,746
6/3/2024	Halley E. Gilbert	Director	Sell	18,200	$73.00	$1,328,600.00	5,625
6/3/2024	Jim Wassil	COO	Sell	3,000	$71.99	$215,970.00	213,503
6/3/2024	Mikhail Eydelman	SVP	Sell	1,667	$72.06	$120,124.02	31,161
5/23/2024	Grant Pickering	CEO	Sell	15,000	$69.43	$1,041,450.00	477,847
5/20/2024	Andrew Guggenhime	CFO	Sell	8,000	$74.99	$599,920.00	95,679
4/23/2024	Grant Pickering	CEO	Sell	15,000	$61.92	$928,800.00	477,847
4/18/2024	Andrew Guggenhime	CFO	Sell	8,000	$61.27	$490,160.00	95,679
3/25/2024	Grant Pickering	CEO	Sell	15,000	$66.93	$1,003,950.00	477,847
3/18/2024	Andrew Guggenhime	CFO	Sell	8,000	$69.02	$552,160.00	95,679
3/1/2024	Elvia Cowan	SVP	Sell	11,678	$74.08	$865,106.24	12,480
3/1/2024	Grant Pickering	CEO	Sell	2,616	$73.70	$192,799.20	148,670
3/1/2024	Jim Wassil	COO	Sell	3,000	$73.71	$221,130.00	220,852
2/1/2024	Grant Pickering	CEO	Sell	2,616	$73.91	$193,348.56	149,978
2/1/2024	Jim Wassil	COO	Sell	3,000	$73.88	$221,640.00	175,935
2/1/2024	Mikhail Eydelman	SVP	Sell	1,667	$73.87	$123,141.29	20,710
1/31/2024	Heath Lukatch	Director	Sell	5,000	$71.50	$357,500.00	5,625
1/29/2024	Grant Pickering	CEO	Sell	30,000	$66.03	$1,980,900.00	375,814
1/29/2024	Heath Lukatch	Director	Sell	4,000	$67.50	$270,000.00	5,625
1/23/2024	Grant Pickering	CEO	Sell	15,000	$63.92	$958,800.00	375,814
1/18/2024	Andrew Guggenhime	CFO	Sell	8,000	$60.73	$485,840.00	79,474
1/2/2024	Grant Pickering	CEO	Sell	2,616	$63.89	$167,136.24	151,286
1/2/2024	Heath Lukatch	Director	Sell	13,000	$63.76	$828,880.00	5,625
1/2/2024	Jim Wassil	COO	Sell	3,000	$63.91	$191,730.00	175,935
1/2/2024	Mikhail Eydelman	SVP	Sell	1,667	$63.93	$106,571.31	20,710
12/26/2023	Grant Pickering	CEO	Sell	15,000	$61.70	$925,500.00	375,814
12/18/2023	Andrew Guggenhime	CFO	Sell	8,000	$60.18	$481,440.00	79,474
12/7/2023	Mikhail Eydelman	SVP	Sell	10,000	$56.50	$565,000.00	21,035
11/24/2023	Grant Pickering	CEO	Sell	15,000	$49.09	$736,350.00	370,914
11/20/2023	Andrew Guggenhime	CFO	Sell	8,000	$51.13	$409,040.00	79,474
11/1/2023	Grant Pickering	CEO	Sell	2,618	$47.29	$123,805.22	153,903
11/1/2023	Jim Wassil	COO	Sell	3,000	$47.26	$141,780.00	175,935
10/23/2023	Grant Pickering	CEO	Sell	15,000	$47.07	$706,050.00	385,914
10/18/2023	Andrew Guggenhime	CFO	Sell	8,000	$45.91	$367,280.00	79,474
10/2/2023	Grant Pickering	CEO	Sell	2,618	$50.42	$131,999.56	155,212
10/2/2023	Jim Wassil	COO	Sell	3,000	$50.43	$151,290.00	170,935
10/2/2023	Mikhail Eydelman	SVP	Sell	20,000	$50.40	$1,008,000.00	20,487
9/25/2023	Grant Pickering	CEO	Sell	15,000	$52.45	$786,750.00	400,914
9/1/2023	Jim Wassil	COO	Sell	3,000	$52.82	$158,460.00	170,066
1/10/2023	Heath Lukatch	Director	Sell	315	$46.12	$14,527.80	3,125
12/12/2022	Heath Lukatch	Director	Sell	335	$43.93	$14,716.55	3,125
11/10/2022	Heath Lukatch	Director	Sell	4,335	$46.13	$199,973.55	3,125
10/26/2022	Heath Lukatch	Director	Sell	4,000	$38.25	$153,000.00	3,125
10/26/2022	Jeff Fairman	VP	Sell	10,000	$40.00	$400,000.00	286,227
10/24/2022	Heath Lukatch	Director	Sell	3,015	$35.11	$105,856.65	3,125
10/17/2022	Jim Wassil	COO	Sell	2,800	$25.72	$72,016.00	42,344
10/11/2022	Jeff Fairman	VP	Sell	5,000	$25.50	$127,500.00	296,227
9/26/2022	Grant Pickering	CEO	Sell	10,000	$24.71	$247,100.00	157,830
9/19/2022	Andrew Guggenhime	CFO	Sell	3,100	$26.10	$80,910.00	37,538
9/19/2022	Jim Wassil	COO	Sell	2,800	$26.11	$73,108.00	42,344
9/15/2022	Grant Pickering	CEO	Sell	11,000	$27.95	$307,450.00	652,546
8/29/2022	Andrew Guggenhime	CFO	Sell	17,653	$28.00	$494,284.00	42,187
8/26/2022	Andrew Guggenhime	CFO	Sell	1,295	$28.00	$36,260.00	42,187
8/26/2022	Grant Pickering	CEO	Sell	10,000	$27.44	$274,400.00	162,830
8/22/2022	Paul Sauer	SVP	Sell	3,000	$25.93	$77,790.00	14,687
8/18/2022	Andrew Guggenhime	CFO	Sell	3,100	$25.26	$78,306.00	42,187
8/17/2022	Jim Wassil	COO	Sell	2,800	$25.15	$70,420.00	44,506
8/4/2022	Jeff Fairman	VP	Sell	10,000	$25.50	$255,000.00	311,227
7/27/2022	Paul Sauer	SVP	Sell	3,000	$25.00	$75,000.00	17,687
7/26/2022	Grant Pickering	CEO	Sell	10,000	$23.27	$232,700.00	167,830
7/20/2022	Paul Sauer	SVP	Sell	3,000	$25.00	$75,000.00	20,687
7/18/2022	Andrew Guggenhime	CFO	Sell	3,100	$24.53	$76,043.00	42,187
7/15/2022	Grant Pickering	CEO	Sell	11,000	$24.47	$269,170.00	683,456
7/8/2022	Andrew Guggenhime	CFO	Sell	3,100	$24.00	$74,400.00	42,187
7/1/2022	Jim Wassil	COO	Sell	2,800	$22.00	$61,600.00	44,506
6/28/2022	Grant Pickering	CEO	Sell	10,000	$21.00	$210,000.00	345,660
6/23/2022	Grant Pickering	CEO	Sell	3,541	$21.01	$74,396.41	695,203
6/21/2022	Grant Pickering	CEO	Sell	5,451	$21.05	$114,743.55	700,005
5/23/2022	Paul Sauer	SVP	Sell	3,000	$26.22	$78,660.00	23,687
5/20/2022	Jeff Fairman	VP	Sell	4,112	$25.50	$104,856.00	321,227
5/18/2022	Andrew Guggenhime	CFO	Sell	3,100	$24.44	$75,764.00	42,187
5/16/2022	Grant Pickering	CEO	Sell	11,000	$23.91	$263,010.00	703,894
5/5/2022	Jeff Fairman	VP	Sell	888	$25.80	$22,910.40	325,339
4/22/2022	Paul Sauer	SVP	Sell	3,000	$25.00	$75,000.00	25,125
4/18/2022	Andrew Guggenhime	CFO	Sell	3,100	$24.05	$74,555.00	40,625
4/18/2022	Grant Pickering	CEO	Sell	11,000	$23.98	$263,780.00	703,894
4/18/2022	Jim Wassil	COO	Sell	2,800	$23.98	$67,144.00	42,944
4/5/2022	Jeff Fairman	VP	Sell	5,000	$25.59	$127,950.00	16,629
3/22/2022	Paul Sauer	SVP	Sell	3,000	$25.00	$75,000.00
3/21/2022	Grant Pickering	CEO	Sell	14,288	$24.94	$356,342.72
3/11/2022	Jeff Fairman	VP	Sell	10,000	$25.50	$255,000.00
3/10/2022	Paul Sauer	SVP	Sell	6,000	$25.00	$150,000.00
2/24/2022	Jim Wassil	COO	Sell	10,000	$22.00	$220,000.00
12/29/2021	Paul Sauer	SVP	Sell	6,000	$25.00	$150,000.00
12/27/2021	Jeff Fairman	VP	Sell	4,750	$23.60	$112,100.00
12/23/2021	Andrew Guggenhime	CFO	Sell	3,100	$24.00	$74,400.00

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Vaxcyte (NASDAQ:PCVX)

96.78% of Vaxcyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vaxcyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	52,702	$6.02M	0.0%	+186.2%	0.042%
12/13/2024	Lord Abbett & CO. LLC	312,425	$35.70M	0.1%	+26.9%	0.251%
11/27/2024	Franklin Resources Inc.	2,786,335	$315.16M	0.1%	+13.2%	2.236%
11/25/2024	Sanctuary Advisors LLC	4,437	$0.51M	0.0%	N/A	0.004%
11/20/2024	Virtu Financial LLC	3,110	$0.36M	0.0%	N/A	0.002%
11/18/2024	Teachers Retirement System of The State of Kentucky	21,320	$2.44M	0.0%	-14.9%	0.017%
11/16/2024	Geode Capital Management LLC	2,700,782	$308.68M	0.0%	+10.6%	2.167%
11/15/2024	Frazier Life Sciences Management L.P.	879,405	$100.49M	4.0%	-15.4%	0.706%
11/15/2024	Nomura Asset Management Co. Ltd.	806	$92K	0.0%	N/A	0.001%
11/15/2024	Y Intercept Hong Kong Ltd	26,019	$2.97M	0.2%	+148.7%	0.021%
11/15/2024	MML Investors Services LLC	2,274	$0.26M	0.0%	N/A	0.002%
11/15/2024	Pier Capital LLC	47,567	$5.44M	0.8%	-58.6%	0.038%
11/15/2024	Orion Portfolio Solutions LLC	2,590	$0.30M	0.0%	-43.5%	0.002%
11/15/2024	Zacks Investment Management	13,645	$1.56M	0.0%	N/A	0.011%
11/15/2024	Castleark Management LLC	54,620	$6.24M	0.3%	+25.0%	0.044%
11/15/2024	Wellington Management Group LLP	4,513,756	$515.79M	0.1%	-1.7%	3.621%
11/15/2024	Wolverine Trading LLC	3,033	$0.34M	0.0%	N/A	0.002%
11/15/2024	State Street Corp	3,405,743	$389.17M	0.0%	+1.1%	2.732%
11/15/2024	RA Capital Management L.P.	8,689,190	$992.91M	11.4%	+5.9%	6.971%
11/15/2024	Point72 Asset Management L.P.	359,796	$41.11M	0.1%	N/A	0.289%
11/15/2024	Polar Asset Management Partners Inc.	54,000	$6.17M	0.1%	-45.0%	0.043%
11/15/2024	Parkman Healthcare Partners LLC	130,249	$14.88M	1.9%	-13.3%	0.105%
11/15/2024	Maven Securities LTD	129,700	$14.82M	0.3%	N/A	0.104%
11/15/2024	Janus Henderson Group PLC	10,921,896	$1.25B	0.6%	+23.1%	8.763%
11/15/2024	HighVista Strategies LLC	44,661	$5.10M	1.8%	+38.2%	0.036%
11/15/2024	Cinctive Capital Management LP	32,494	$3.71M	0.2%	N/A	0.026%
11/15/2024	Bamco Inc. NY	31,000	$3.54M	0.0%	N/A	0.025%
11/14/2024	Bellevue Group AG	11,981	$1.37M	0.0%	-15.7%	0.010%
11/14/2024	Maverick Capital Ltd.	976,249	$111.56M	2.2%	+41.9%	0.783%
11/14/2024	Fred Alger Management LLC	1,243,717	$142.12M	0.7%	-5.1%	0.998%
11/14/2024	Braidwell LP	297,568	$34M	1.0%	-63.2%	0.239%
11/14/2024	Eventide Asset Management LLC	383,454	$43.82M	0.8%	-48.1%	0.308%
11/14/2024	Verition Fund Management LLC	4,275	$0.49M	0.0%	N/A	0.003%
11/14/2024	Martingale Asset Management L P	15,605	$1.78M	0.0%	-9.6%	0.013%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	408,274	$46.65M	0.0%	+38.0%	0.328%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	21,311	$2.44M	0.0%	+4.0%	0.017%
11/14/2024	Acuta Capital Partners LLC	135,400	$15.47M	12.5%	+22.6%	0.109%
11/14/2024	FORA Capital LLC	34,379	$3.93M	0.5%	N/A	0.028%
11/14/2024	MetLife Investment Management LLC	67,833	$7.75M	0.0%	+7.7%	0.054%
11/13/2024	Glenmede Trust Co. NA	6,967	$0.80M	0.0%	-42.0%	0.006%
11/13/2024	FMR LLC	15,800,667	$1.81B	0.1%	-2.3%	12.677%
11/13/2024	The Manufacturers Life Insurance Company	157,024	$17.94M	0.0%	+19.2%	0.126%
11/13/2024	Bank of Montreal Can	27,433	$3.10M	0.0%	N/A	0.022%
11/13/2024	Bank of Hawaii	15,023	$1.72M	0.1%	-1.0%	0.012%
11/12/2024	Westfield Capital Management Co. LP	1,739,874	$198.82M	0.9%	-9.8%	1.396%
11/12/2024	Algert Global LLC	39,292	$4.49M	0.1%	+13.1%	0.032%
11/12/2024	Citigroup Inc.	220,543	$25.20M	0.0%	+33.0%	0.177%
11/12/2024	Valence8 US LP	2,468	$0.28M	0.1%	N/A	0.002%
11/12/2024	Eagle Asset Management Inc.	176,249	$18.80M	0.1%	-37.6%	0.141%
11/12/2024	Charles Schwab Investment Management Inc.	1,295,837	$148.08M	0.0%	+47.9%	1.040%
11/9/2024	Intech Investment Management LLC	28,228	$3.23M	0.0%	N/A	0.023%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	70,037	$8M	0.0%	+59.4%	0.056%
11/8/2024	Jennison Associates LLC	1,237,430	$141.40M	0.1%	-10.5%	0.993%
11/8/2024	Segall Bryant & Hamill LLC	156,056	$17.83M	0.2%	-3.9%	0.140%
11/8/2024	Avior Wealth Management LLC	5,332	$0.61M	0.0%	-8.6%	0.005%
11/8/2024	B. Metzler seel. Sohn & Co. Holding AG	10,409	$1.19M	0.0%	N/A	0.009%
11/7/2024	Meeder Asset Management Inc.	698	$80K	0.0%	+1,007.9%	0.001%
11/7/2024	Pathstone Holdings LLC	30,527	$3.49M	0.0%	+7.6%	0.027%
11/7/2024	First Turn Management LLC	211,985	$24.22M	3.8%	-18.6%	0.190%
11/7/2024	Swiss National Bank	180,600	$20.64M	0.0%	-0.4%	0.162%
11/6/2024	Mutual of America Capital Management LLC	50,341	$5.75M	0.1%	-0.9%	0.045%
11/6/2024	Natixis Advisors LLC	22,697	$2.59M	0.0%	+61.1%	0.020%
11/6/2024	CIBC Asset Management Inc	3,136	$0.36M	0.0%	+3.6%	0.003%
11/6/2024	Curi RMB Capital LLC	7,901	$0.90M	0.0%	N/A	0.007%
11/6/2024	KBC Group NV	2,683	$0.31M	0.0%	+13.6%	0.002%
11/6/2024	Oppenheimer & Co. Inc.	4,459	$0.51M	0.0%	N/A	0.004%
11/6/2024	Oppenheimer Asset Management Inc.	3,274	$0.37M	0.0%	-10.7%	0.003%
11/5/2024	Victory Capital Management Inc.	255,040	$29.14M	0.0%	-17.1%	0.229%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	5,649	$0.65M	0.0%	+24.7%	0.005%
11/5/2024	WCM Investment Management LLC	140,847	$15.94M	0.0%	+52.6%	0.126%
11/4/2024	Lisanti Capital Growth LLC	32,515	$3.72M	0.9%	+68.1%	0.029%
11/4/2024	Chartwell Investment Partners LLC	14,146	$1.62M	0.1%	+24.1%	0.013%
11/4/2024	Los Angeles Capital Management LLC	8,895	$1.02M	0.0%	N/A	0.008%
11/4/2024	Baker Avenue Asset Management LP	13,143	$1.50M	0.0%	-3.7%	0.012%
11/4/2024	TimesSquare Capital Management LLC	269,121	$30.75M	0.5%	N/A	0.241%
11/2/2024	Covestor Ltd	1,057	$0.12M	0.1%	-8.3%	0.001%
11/1/2024	Atria Investments Inc	2,507	$0.29M	0.0%	N/A	0.002%
10/31/2024	Principal Financial Group Inc.	52,702	$6.02M	0.0%	+186.2%	0.047%
10/30/2024	Amalgamated Bank	4,081	$0.47M	0.0%	+8.6%	0.004%
10/29/2024	Harbor Capital Advisors Inc.	64,664	$7.39M	0.3%	+60.3%	0.058%
10/29/2024	Chicago Partners Investment Group LLC	4,973	$0.56M	0.0%	-1.8%	0.004%
10/28/2024	US Bancorp DE	7,042	$0.81M	0.0%	-21.8%	0.006%
10/25/2024	China Universal Asset Management Co. Ltd.	21,466	$2.45M	0.3%	+68.0%	0.019%
10/25/2024	abrdn plc	82,830	$9.47M	0.0%	-56.5%	0.074%
10/24/2024	Nisa Investment Advisors LLC	2,209	$0.25M	0.0%	+5.2%	0.002%
10/24/2024	Novo Holdings A S	750,000	$85.70M	4.3%	-21.1%	0.672%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	15,011	$1.70M	0.0%	+28.7%	0.013%
10/23/2024	Mount Yale Investment Advisors LLC	4,000	$0.46M	0.0%	-19.5%	0.004%
10/23/2024	Values First Advisors Inc.	1,527	$0.17M	0.1%	N/A	0.001%
10/23/2024	Moody Aldrich Partners LLC	54,169	$6.19M	1.1%	-46.0%	0.049%
10/22/2024	Bank Pictet & Cie Europe AG	3,805	$0.44M	0.0%	-2.3%	0.003%
10/22/2024	Signaturefd LLC	1,048	$0.12M	0.0%	+51.9%	0.001%
10/19/2024	Allspring Global Investments Holdings LLC	347,474	$39.71M	0.1%	+1.1%	0.311%
10/18/2024	Raymond James & Associates	81,235	$9.28M	0.0%	+17.0%	0.075%
10/18/2024	Blue Trust Inc.	371	$42K	0.0%	+33.5%	0.000%
10/18/2024	Riverview Trust Co	236	$27K	0.0%	N/A	0.000%
10/11/2024	Creative Planning	37,525	$4.29M	0.0%	+37.6%	0.034%
10/5/2024	Handelsbanken Fonder AB	27,100	$3.10M	0.0%	-0.7%	0.024%
10/3/2024	SG Americas Securities LLC	9,530	$1.09M	0.0%	+306.9%	0.009%
8/27/2024	Clearbridge Investments LLC	186,141	$14.06M	0.0%	N/A	0.171%

Data available starting January 2016

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Today's Range

Now: $86.53

$86.25

$88.90

50 Day Range

MA: $98.70

$85.75

$117.93

52 Week Range

Now: $86.53

$53.83

$121.06

Volume

3,859,357 shs

Average Volume

922,601 shs

Market Capitalization

$10.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Vaxcyte?: Vaxcyte's top insider shareholders include:
Grant Pickering (CEO)
Jim Wassil (COO)
Andrew Guggenhime (CFO)
Mikhail Eydelman (SVP)
Elvia Cowan (SVP)
Halley E Gilbert (Director)
Heath Lukatch (Director)
Learn More about top insider investors at Vaxcyte.
Who are the major institutional investors of Vaxcyte?: Vaxcyte's top institutional investors include:
FMR LLC — 12.68%
Janus Henderson Group PLC — 8.76%
RA Capital Management L.P. — 6.97%
Wellington Management Group LLP — 3.62%
State Street Corp — 2.73%
Franklin Resources Inc. — 2.24%
Learn More about top institutional investors of Vaxcyte stock.
Which major investors are selling Vaxcyte stock?: During the last quarter, PCVX stock was sold by these institutional investors:
Braidwell LP
FMR LLC
Eventide Asset Management LLC
Novo Holdings A S
Westfield Capital Management Co. LP
Frazier Life Sciences Management L.P.
Jennison Associates LLC
abrdn plc
In the previous year, company insiders that have sold Vaxcyte company stock include:
Grant Pickering (CEO)
Jim Wassil (COO)
Andrew Guggenhime (CFO)
Mikhail Eydelman (SVP)
Elvia Cowan (SVP)
Halley E Gilbert (Director)
Heath Lukatch (Director)
Learn More investors selling Vaxcyte stock.
Which major investors are buying Vaxcyte stock?: Within the last quarter, PCVX stock was acquired by institutional investors including:
Janus Henderson Group PLC
RA Capital Management L.P.
Charles Schwab Investment Management Inc.
Point72 Asset Management L.P.
Franklin Resources Inc.
Maverick Capital Ltd.
TimesSquare Capital Management LLC
Geode Capital Management LLC

AI breakthrough about to upend industry